RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1
RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1
The classical paradigm of mutation screening seeks to relate alterations in DNA sequence to their effect at the protein level. However, the majority of missense mutations are problematic as their pathological significance is often unclear. In order to test the hypothesis that many missense mutations primarily cause defects at the RNA rather than the protein level, we have performed retrospective RNA analysis of 12 individuals carrying missense mutations in the cancer predisposition genes APC, BRCA1, BRCA2, MLH1, and MSH2. RNA was extracted from peripheral blood samples and RT-PCR performed in order to assess the splicing and expression of the mutant allele in each case. Four of the 12 missense mutations analysed were associated with RNA defects. We detected two cases of exon skipping and one case of partial intron inclusion with activation of a cryptic intronic splice site in MLH1. A fourth case was associated with monoallelic expression of BRCA1. In addition, allele-specific analysis of common coding polymorphisms identified a further case of monoallelic BRCA1 expression in one of two individuals who had previously screened as mutation-negative. Although we were unable to identify the underlying cause of this loss of expression, it strongly suggests the presence of a pathogenic defect in BRCA1 in this case, highlighting the use of allelic expression studies as a method of mutation scanning. Finally, we used our dataset to test the ability of several in silico sequence analysis tools to identify splicing defects. Our results suggest that a significant number of missense mutations in cancer predisposition genes are associated with defects of RNA splicing, and that the use of gene- and splice site prediction software can aid in identifying such mutations.
splicing, exon splice enhancer, ese, brca1, brca2, mlh1, msh2
272-272
Sharp, Andrew
ee3d8496-53a4-40de-ba16-add24d70b515
Pichert, Gabriella
2f767134-7791-42b4-9b80-50e978ab2495
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
September 2004
Sharp, Andrew
ee3d8496-53a4-40de-ba16-add24d70b515
Pichert, Gabriella
2f767134-7791-42b4-9b80-50e978ab2495
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Sharp, Andrew, Pichert, Gabriella, Lucassen, Anneke and Eccles, Diana
(2004)
RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.
Human Mutation, 24 (3), .
(doi:10.1002/humu.9267).
Abstract
The classical paradigm of mutation screening seeks to relate alterations in DNA sequence to their effect at the protein level. However, the majority of missense mutations are problematic as their pathological significance is often unclear. In order to test the hypothesis that many missense mutations primarily cause defects at the RNA rather than the protein level, we have performed retrospective RNA analysis of 12 individuals carrying missense mutations in the cancer predisposition genes APC, BRCA1, BRCA2, MLH1, and MSH2. RNA was extracted from peripheral blood samples and RT-PCR performed in order to assess the splicing and expression of the mutant allele in each case. Four of the 12 missense mutations analysed were associated with RNA defects. We detected two cases of exon skipping and one case of partial intron inclusion with activation of a cryptic intronic splice site in MLH1. A fourth case was associated with monoallelic expression of BRCA1. In addition, allele-specific analysis of common coding polymorphisms identified a further case of monoallelic BRCA1 expression in one of two individuals who had previously screened as mutation-negative. Although we were unable to identify the underlying cause of this loss of expression, it strongly suggests the presence of a pathogenic defect in BRCA1 in this case, highlighting the use of allelic expression studies as a method of mutation scanning. Finally, we used our dataset to test the ability of several in silico sequence analysis tools to identify splicing defects. Our results suggest that a significant number of missense mutations in cancer predisposition genes are associated with defects of RNA splicing, and that the use of gene- and splice site prediction software can aid in identifying such mutations.
This record has no associated files available for download.
More information
Published date: September 2004
Additional Information:
Mutation in brief
Keywords:
splicing, exon splice enhancer, ese, brca1, brca2, mlh1, msh2
Identifiers
Local EPrints ID: 26602
URI: http://eprints.soton.ac.uk/id/eprint/26602
ISSN: 1059-7794
PURE UUID: 93a72938-0f15-468e-8f63-8f2f395dc01b
Catalogue record
Date deposited: 20 Apr 2006
Last modified: 16 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
Andrew Sharp
Author:
Gabriella Pichert
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics